The table shows the 10 prescription medications that had price increases in 2021 that were unsupported by new clinical evidence. Reprinted with permission. Source: Rind DM, Agboola F, Campbell J, Nikitin D, et al. Unsupported Price Increase Report: Unsupported Price Increases Occurring in 2021. December 6, 2022. ICER.
Last year, the makers of seven widely used prescription drugs raised prices substantially without any new clinical evidence to justify the increases, Ed Silverman reported at STAT News last week.
Silverman based his reporting on an analysis from the independent nonprofit Institute for Clinical and Economic Review (ICER) that analyzes evidence on the effectiveness and value of drugs and other medical services. ICER released that report, “Unsupported Price Increases (UPI) of prescription drugs in the United States,” on Tuesday, Dec. 6.
Continue reading →
Joseph Burns (@jburns18), an independent journalist who resides in Brewster, Massachusetts, is AHCJ’s topic leader on health reform. He welcomes questions and suggestions and tip sheets at email@example.com.